bioAffinity Technologies Reports Q3 Revenue of $1.1 Million and GAAP EPS of -$5.89
bioAffinity Technologies (NASDAQ: BIAF) has released its third-quarter financial results, reporting a GAAP earnings per share (EPS) loss of $5.89. The company's revenue for the period reached $1.1 million, representing a 21.4% decrease compared to the same period last year. The company's liquidity position has seen a significant decline, with cash and cash equivalents dropping to approximately $2.6 million as of September 30, 2026, down from $6.4 million at the end of December 2025. This contraction in capital follows recent corporate actions including a 1-for-15 reverse stock split and a $4 million private placement.
Tickers: $BIAF
Topics: cash position earnings report net loss revenue decline